TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 205 participants.
Also called NCT04570228
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 205 participants
- Sponsor
- SoniVie Inc.
- Registry
-
NCT04570228
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04570228. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-01 (anticipated); primary completion 2023-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Device)
- Pulmonary artery denervation
- Intervention (Device)
- Sham procedure
- Lead sponsor
- SoniVie Inc.
Record details
- Record id
cardio:ct-nct04570228- Content hash
686be71d9659ecab6ca7021a5133db91e3eb5a9d463b7df108f12b981083f1a9